181269-70-5 Usage
General Description
N-Boc-3-methyl-4-hydroxypiperidine is a chemical compound with the molecular formula C11H21NO3. It is a piperidine derivative that contains a tert-butoxycarbonyl (Boc) protecting group, a methyl group, and a hydroxy group attached to the piperidine ring. N-Boc-3-methyl-4-hydroxypiperidine is commonly used in organic synthesis as a building block for the preparation of various pharmaceuticals, agrochemicals, and other fine chemicals. It is also used as a reagent in the synthesis of heterocyclic compounds and other organic molecules. Additionally, N-Boc-3-methyl-4-hydroxypiperidine has been studied for its potential biological and pharmacological activities, making it a versatile and important compound in the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 181269-70-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,1,2,6 and 9 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 181269-70:
(8*1)+(7*8)+(6*1)+(5*2)+(4*6)+(3*9)+(2*7)+(1*0)=145
145 % 10 = 5
So 181269-70-5 is a valid CAS Registry Number.
181269-70-5Relevant articles and documents
DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS
-
Paragraph 0170, (2018/03/28)
Compounds of formula I: I are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disorders in a patient in need are also disclosed. Such disorders include depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, autism, a cognitive impairment, or a neuropsychiatric symptom such as apathy, depression, anxiety, psychosis, aggression, agitation, impulse control disorders, and sleep disorders in neurological disorders such as Alzheimer's and Parkinson's diseases.
THERAPEUTIC COMPOUNDS
-
Paragraph 0625; 0626; 0627; 0628, (2014/01/07)
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof in which m, n, W, X, Y, Z, R, R1, R2, R3 and R4 are as defined in the specification, for use in therapy.
PIPERIDINE AMIDE DERIVATIVES AS PROTEIN KINASE INHIBITORS
-
Page/Page column 34-35, (2010/11/28)
-